Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
American Journal of Surgery|February 1, 2016
Association of sentinel lymph node diameter with melanoma metastasisJustin Merkow, Alessandro Paniccia, Edward Jones, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanomaKatherine Zukotynski, Jeffrey T Yap, Anita Giobbie-Hurder, et al.Cancer|April 2, 2011
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanomaJohn M Kirkwood, Rene Gonzalez, Douglas Reintgen, et al.JAMA Surgery|January 18, 2013
Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy resultEdward L Jones, Teresa S Jones, Nathan W Pearlman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patientsKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanomaRobert W Weber, Steven O'Day, Madalene Rose, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanomaKarl D Lewis, William A Robinson, Martin McCarter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesMayer N Fishman, John A Thompson, Gregory K Pennock, et al.Pageof 15